Your browser doesn't support javascript.
loading
ADAM8 as a drug target in pancreatic cancer.
Schlomann, Uwe; Koller, Garrit; Conrad, Catharina; Ferdous, Taheera; Golfi, Panagiota; Garcia, Adolfo Molejon; Höfling, Sabrina; Parsons, Maddy; Costa, Patricia; Soper, Robin; Bossard, Maud; Hagemann, Thorsten; Roshani, Rozita; Sewald, Norbert; Ketchem, Randal R; Moss, Marcia L; Rasmussen, Fred H; Miller, Miles A; Lauffenburger, Douglas A; Tuveson, David A; Nimsky, Christopher; Bartsch, Jörg W.
Afiliación
  • Schlomann U; 1] King's College London, Institute for Pharmaceutical Science and KCLDI, London SE1 9RT, UK [2] Department of Neurosurgery, Marburg University, , Baldingerstrasse, 35033 Marburg, Germany.
  • Koller G; King's College London, Institute for Pharmaceutical Science and KCLDI, London SE1 9RT, UK.
  • Conrad C; Department of Neurosurgery, Marburg University, , Baldingerstrasse, 35033 Marburg, Germany.
  • Ferdous T; King's College London, Institute for Pharmaceutical Science and KCLDI, London SE1 9RT, UK.
  • Golfi P; King's College London, Institute for Pharmaceutical Science and KCLDI, London SE1 9RT, UK.
  • Garcia AM; King's College London, Institute for Pharmaceutical Science and KCLDI, London SE1 9RT, UK.
  • Höfling S; King's College London, Institute for Pharmaceutical Science and KCLDI, London SE1 9RT, UK.
  • Parsons M; King's College London, Randall Institute, London SE1 8RT, UK.
  • Costa P; Institute of Cancer and Inflammation, St Mary's School of Medicine, John Vane Building, Charterhouse Square, London, EC1M 6BQ, UK.
  • Soper R; Institute of Cancer and Inflammation, St Mary's School of Medicine, John Vane Building, Charterhouse Square, London, EC1M 6BQ, UK.
  • Bossard M; Institute of Cancer and Inflammation, St Mary's School of Medicine, John Vane Building, Charterhouse Square, London, EC1M 6BQ, UK.
  • Hagemann T; Institute of Cancer and Inflammation, St Mary's School of Medicine, John Vane Building, Charterhouse Square, London, EC1M 6BQ, UK.
  • Roshani R; Institute of Cancer and Inflammation, St Mary's School of Medicine, John Vane Building, Charterhouse Square, London, EC1M 6BQ, UK.
  • Sewald N; Department of Organic Chemistry, Bielefeld University, 33615 Bielefeld, Germany.
  • Ketchem RR; Therapeutic Discovery, AMGEN Inc., Seattle, Washington 98119, USA.
  • Moss ML; Biozyme Inc., Apex, North Carolina 27523, USA.
  • Rasmussen FH; Biozyme Inc., Apex, North Carolina 27523, USA.
  • Miller MA; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.
  • Lauffenburger DA; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.
  • Tuveson DA; Cold Spring Harbor Laboratory, Cold Spring Harbor, New York 11791, USA.
  • Nimsky C; Department of Neurosurgery, Marburg University, , Baldingerstrasse, 35033 Marburg, Germany.
  • Bartsch JW; 1] King's College London, Institute for Pharmaceutical Science and KCLDI, London SE1 9RT, UK [2] Department of Neurosurgery, Marburg University, , Baldingerstrasse, 35033 Marburg, Germany.
Nat Commun ; 6: 6175, 2015 Jan 28.
Article en En | MEDLINE | ID: mdl-25629724

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Proteínas ADAM / Terapia Molecular Dirigida / Proteínas de la Membrana Límite: Animals / Humans Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2015 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Proteínas ADAM / Terapia Molecular Dirigida / Proteínas de la Membrana Límite: Animals / Humans Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2015 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Reino Unido